Hakutulokset - Han Tian

  • Näytetään 1 - 3 yhteensä 3 tuloksesta
Tarkenna hakua
  1. 1
  2. 2

    Inhibition of ARH2 by pH/ROS-responsive nanosystem for improved lung adenocarcinoma immunochemotherapy Tekijä Rui Cai, Meng Wang, Mengting Pan, Zhiwu Zhang, Qiang Jia, Longbao Feng, Zhongjian Yu, Lu Liu, Tongyu Zhu, Silin Cai, Han Tian, Jiangyu Zhang, Rui Guo, Yanfang Zheng

    Julkaistu 2025-11-01

    Immunotherapy resistance remains a substantial barrier to improving treatment outcomes for patients with lung adenocarcinoma (LUAD). Identifying effective immunotherapy target is crucial for enhancing therapeutic efficacy in LUAD. Through database analysis, we discovered that ADP ribosylhydrolase-li...

    Täydet tiedot

    Hae kokoteksti
    Artikkeli
  3. 3

    Hepatoprotective drug screening identifies daclatasvir, a promising therapeutic candidate for MASLD by targeting PLIN2 Tekijä Rui Shu, Song Tian, Weiyi Qu, Jinjie Yang, Wei Shi, Xinyan Li, Toujun Zou, Changjin Jiang, Yuxuan Zhang, Zifeng Yang, Han Tian, Hailong Yang, Jiajun Fu, Zhi-Gang She, Hongliang Li, Xiao-Jing Zhang

    Julkaistu 2025-07-01

    Metabolic dysfunction-associated steatohepatitis (MASH) has become a global health challenge with limited therapeutic strategy. Here, this study aims to identify promising drug candidates for MASH and clarify its pharmacological mechanism. By extensive screening of FDA-approved hepatoprotective medi...

    Täydet tiedot

    Hae kokoteksti
    Artikkeli